- Home
- XBIT vs SENS Comparison
XBIT vs SENS Comparison
Compare XBIT & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- SENS
- Stock Information
- Founded
- XBIT 2005
- SENS 1996
- Country
- XBIT United States
- SENS United States
- Employees
- XBIT N/A
- SENS N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- SENS Industrial Machinery/Components
- Sector
- XBIT Health Care
- SENS Industrials
- Exchange
- XBIT Nasdaq
- SENS Nasdaq
- Market Cap
- XBIT 86.3M
- SENS 357.2M
- IPO Year
- XBIT 2015
- SENS N/A
- Fundamental
- Price
- XBIT $2.72
- SENS $0.45
- Analyst Decision
- XBIT
- SENS Strong Buy
- Analyst Count
- XBIT 0
- SENS 5
- Target Price
- XBIT N/A
- SENS $1.63
- AVG Volume (30 Days)
- XBIT 52.7K
- SENS 5.0M
- Earning Date
- XBIT 11-12-2025
- SENS 11-06-2025
- Dividend Yield
- XBIT N/A
- SENS N/A
- EPS Growth
- XBIT N/A
- SENS N/A
- EPS
- XBIT N/A
- SENS N/A
- Revenue
- XBIT N/A
- SENS $25,466,000.00
- Revenue This Year
- XBIT N/A
- SENS $63.52
- Revenue Next Year
- XBIT N/A
- SENS $67.91
- P/E Ratio
- XBIT N/A
- SENS N/A
- Revenue Growth
- XBIT N/A
- SENS 5.94
- 52 Week Low
- XBIT $2.50
- SENS $0.25
- 52 Week High
- XBIT $8.32
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- XBIT 34.88
- SENS 44.99
- Support Level
- XBIT $2.72
- SENS $0.44
- Resistance Level
- XBIT $3.61
- SENS $0.46
- Average True Range (ATR)
- XBIT 0.18
- SENS 0.02
- MACD
- XBIT -0.05
- SENS 0.00
- Stochastic Oscillator
- XBIT 2.20
- SENS 23.47
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.